Directors' Dealing (7506D)
March 28 2011 - 9:27AM
UK Regulatory
TIDMAGI
RNS Number : 7506D
AGI Therapeutics plc
28 March 2011
AGI Therapeutics plc
('AGI' or the 'Company')
Directors' Dealing
AGI was informed on 25 March 2011 that David Kelly, a Director
and Chief Financial Officer of AGI, purchased 550,000 ordinary
shares of EUR0.01 each ("Ordinary Share") in the share capital of
the Company at a price of EUR0.045 per Ordinary Share on 25 March
2011.
Following this purchase, David Kelly's beneficial shareholding
in the Company is 655,000 Ordinary Shares.
Contact Information:
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPGUMPWUPGGWR
AGI (LSE:AGI)
Historical Stock Chart
From Jan 2025 to Feb 2025
AGI (LSE:AGI)
Historical Stock Chart
From Feb 2024 to Feb 2025
